The PROMISE Registry & Clinical Trials
Description
In this episode, we explore the groundbreaking PROMISE Registry, a research study aimed at understanding how genetic differences can impact prostate cancer patient outcomes. Our guests, Dr. Channing Paller and Rudy Burwell, share valuable insights on the importance of this collaborative effort between doctors, researchers, and patients in the fight against prostate cancer. The PROMISE Registry is open to all prostate cancer patients, regardless of their stage of treatment or survivorship, and by joining this study, patients can contribute to the development of precision medicine approaches tailored to individual genetic profiles.
We discuss the crucial role of genetics in understanding prostate cancer and how the PROMISE Registry is building a comprehensive genetic database through a grassroots network of patients. By analyzing genetic information from partners nationwide, PROMISE aims to lay the foundation for future prostate cancer knowledge and treatment advancements. Join us as we explore the potential of the PROMISE Registry to revolutionize prostate cancer care and learn how you can be a part of this groundbreaking initiative.
United States
